awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40196279-DC99D2C8-0B05-440E-B40B-3B7EB1EE98BA
Q40196279-DC99D2C8-0B05-440E-B40B-3B7EB1EE98BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40196279-DC99D2C8-0B05-440E-B40B-3B7EB1EE98BA
Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands.
P2860
Q40196279-DC99D2C8-0B05-440E-B40B-3B7EB1EE98BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40196279-DC99D2C8-0B05-440E-B40B-3B7EB1EE98BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f47fe07772a267ca73f5f63ee4b3abfa6171646c
P2860
Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual.